Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response

Affiliations

• ¹ Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia.
• ² Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia; University of New South Wales, Sydney, Australia.
• ³ Department of Dermatology, Liverpool Hospital, Sydney, Australia.
• ⁴ University of New South Wales, Sydney, Australia.
• ⁵ Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia; University of New South Wales, Sydney, Australia. Electronic address: [email protected].